Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 1
2018 10
2019 20
2020 23
2021 27
2022 27
2023 18

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
The asterisk in your search was ignored. You must use 4 or more characters for a wildcard search. Lengthen the root word to search for all endings.
The following term was ignored: (
Quoted phrase not found in phrase index: "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6,11,16,18"
Page 1
Human papillomavirus and cervical cancer.
Okunade KS. Okunade KS. J Obstet Gynaecol. 2020 Jul;40(5):602-608. doi: 10.1080/01443615.2019.1634030. Epub 2019 Sep 10. J Obstet Gynaecol. 2020. PMID: 31500479 Free PMC article. Review.
Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical cancer cases are caused by persistent genital high-risk human papillomavirus (HPV) infection. ...There are currently two effective prophylactic vaccines again …
Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical cancer cases are caused by persistent genital …
Non-sexual HPV transmission and role of vaccination for a better future (Review).
Petca A, Borislavschi A, Zvanca ME, Petca RC, Sandru F, Dumitrascu MC. Petca A, et al. Exp Ther Med. 2020 Dec;20(6):186. doi: 10.3892/etm.2020.9316. Epub 2020 Oct 13. Exp Ther Med. 2020. PMID: 33101476 Free PMC article. Review.
Waterborne transmission of HPV has never been demonstrated; however, HPV DNA has been detected in water environments. ...Once the HPV vaccine program in Australia was launched, many studies reported the initial effects: A decrease in the inciden …
Waterborne transmission of HPV has never been demonstrated; however, HPV DNA has been detected in water environments. ...Once …
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.
Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Kombe Kombe AJ, et al. Front Public Health. 2021 Jan 20;8:552028. doi: 10.3389/fpubh.2020.552028. eCollection 2020. Front Public Health. 2021. PMID: 33553082 Free PMC article. Review.
In addition, vaccination programs face some challenges, leading to a considerable burden of HPV infection and related diseases. Therefore, even though the new (9-valent) vaccine seems promising, next-generation vaccines as well as awareness p …
In addition, vaccination programs face some challenges, leading to a considerable burden of HPV infection and related d …
Fanconi Anemia.
Mehta PA, Ebens C. Mehta PA, et al. 2002 Feb 14 [updated 2021 Jun 3]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. 2002 Feb 14 [updated 2021 Jun 3]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. PMID: 20301575 Free Books & Documents. Review.
Prevention of primary manifestations: Human papilloma virus (HPV) vaccination to reduce the risk for gynecologic cancer in females, and possibly reduce the risk of oral cancer in all individuals. ...Evaluation of relatives at risk: DEB/MMC testing or molecula …
Prevention of primary manifestations: Human papilloma virus (HPV) vaccination to reduce the risk for gynecologic cancer in fem …
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs.
Markowitz LE, Drolet M, Lewis RM, Lemieux-Mellouki P, Pérez N, Jit M, Brotherton JM, Ogilvie G, Kreimer AR, Brisson M. Markowitz LE, et al. Vaccine. 2022 Sep 2;40(37):5413-5432. doi: 10.1016/j.vaccine.2022.06.065. Epub 2022 Aug 12. Vaccine. 2022. PMID: 35965239 Free PMC article. Review.
BACKGROUND: Human papillomavirus (HPV) vaccines were first licensed as a three-dose series. ...Nine evaluated effectiveness against HPV infection, ten anogenital warts, and 16 cervical abnormalities. ...
BACKGROUND: Human papillomavirus (HPV) vaccines were first licensed as a three-dose series. ...Nine evaluated …
Atypical Squamous Cells of Undetermined Significance.
Ndifon CO, Al-Eyd G. Ndifon CO, et al. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 32491671 Free Books & Documents.
However, the explained link between persistent infection with carcinogenic human papillomavirus (HPV) and the development of cervical cancer has paved the way for the advancement of primary and secondary prevention of this type of cancer. The currently used preve …
However, the explained link between persistent infection with carcinogenic human papillomavirus (HPV) and the development of c …
Human papillomavirus in Ethiopia.
Derbie A, Mekonnen D, Yismaw G, Biadglegne F, Van Ostade X, Abebe T. Derbie A, et al. Virusdisease. 2019 Jun;30(2):171-179. doi: 10.1007/s13337-019-00527-4. Epub 2019 Apr 20. Virusdisease. 2019. PMID: 31179353 Free PMC article. Review.
The top five identified genotypes were HPV 16 (45.3%; 95% CI 41.1-49.6%), HPV 52 (9.4%; 95% CI 7.2-12.1%), HPV 18 (8.2%; 95% CI 6.2-10.9%), HPV 58 (6.9%; 95% CI 5.1-9.4%) and HPV 45 (5.2%; 95% CI 3.7-7.5%). The combined prevalence of HPV …
The top five identified genotypes were HPV 16 (45.3%; 95% CI 41.1-49.6%), HPV 52 (9.4%; 95% CI 7.2-12.1%), HPV 18 (8.2% …
Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review.
Ellingson MK, Sheikha H, Nyhan K, Oliveira CR, Niccolai LM. Ellingson MK, et al. Hum Vaccin Immunother. 2023 Aug 1;19(2):2239085. doi: 10.1080/21645515.2023.2239085. Hum Vaccin Immunother. 2023. PMID: 37529935 Free PMC article. Review.
Human papillomavirus (HPV) vaccines work by preventing infections prior to natural exposure. ...We conducted a systematic review of HPV vaccine effectiveness studies published between 2007 and 2022 that included an analysis of effectiv …
Human papillomavirus (HPV) vaccines work by preventing infections prior to natural exposure. ...We conducted a systemat …
Japan's Ongoing Crisis on HPV Vaccination.
Sekine M, Kudo R, Yamaguchi M, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T. Sekine M, et al. Vaccines (Basel). 2020 Jul 6;8(3):362. doi: 10.3390/vaccines8030362. Vaccines (Basel). 2020. PMID: 32640691 Free PMC article. Review.
We reported a high vaccine effectiveness in the group of women vaccinated before their first intercourse (93.9%). The prevalence of cross-protected types of HPV 31/45/52 was also lower in the vaccinated group, and the vaccine effective …
We reported a high vaccine effectiveness in the group of women vaccinated before their first intercourse (93.9%). The p …
Human papillomavirus and cervical cancer.
Okunade KS. Okunade KS. J Obstet Gynaecol. 2019 Dec 11:1-7. doi: 10.1080/01443615.2019.1674261. Online ahead of print. J Obstet Gynaecol. 2019. PMID: 31825273
Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical cancer cases are caused by persistent genital high-risk human papillomavirus (HPV) infection. ...There are currently two effective prophylactic vaccines again …
Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical cancer cases are caused by persistent genital …
110 results